Suki secured $90 million in series E funding to accelerate its growth and expand its artificial intelligence capabilities.
The financing round included new investors Healthier Capital, Crosslink Capital and Hercules Capital. All existing institutional investors also backed the round, including Venrock, Flare Capital Partners, Hedosophia, Philips Ventures and Zoom Ventures.
Suki CEO and Founder Punit Soni told Fierce Healthcare the company is investing in three areas with the fresh capital: advancing its AI, expanding its commercial organization and scaling its partner ecosystem.
“The bigger picture is that healthcare AI is moving beyond documentation,” Soni said. “Health systems want AI that can do more than capture a conversation. They want intelligence that can support clinical decisions, improve financial performance, and streamline operations.”
Soni added the industry “doesn't need another collection of disconnected AI tools.”
“Health systems are already dealing with too many point solutions that don't talk to each other, creating more complexity instead of less,” Soni said. “We believe the answer is a connected, intelligent operating system for healthcare, one that brings AI together across clinical, financial, and operational workflows rather than keeping it confined to individual applications."
Soni continued, “The goal isn't to build every capability ourselves. It's to bring together the best of healthcare AI in a way that works seamlessly for clinicians and health systems. Our vision is much bigger than ambient documentation or any single AI application. We're building toward a future where intelligence connects the entire healthcare experience.”
The company has raised more than $250 million to date, executives say. Patient encounters supported by its tools grew more than 190% year over year in 2026, with revenue doubling in 2025 and on track for similar growth this year.
Suki now works with more than 250 healthcare organizations and more than 30 technology partners that embed its AI into their platforms, executives say.
Healthier Capital Partner Aman Mahajan, M.D., Ph.D., will join Suki’s board as part of the financing. Mahajan said in a statement the “real opportunity for AI in healthcare” isn’t automating individual tasks, but rather “to rethink how work gets done across the health system.”
“What makes Suki particularly compelling is its dual approach: delivering AI directly to clinicians through its own application, Suki for Clinicians, while also powering AI capabilities within the platforms and technologies healthcare organizations already use,” Mahajan said. “Combined with its sophisticated AI, deep clinical integrations, and demonstrated outcomes, this approach gives Suki a unique opportunity to scale intelligence across healthcare. We believe Suki can become the foundational infrastructure for how healthcare operates in the AI era.”
The funding announcement comes fresh off the launch of Suki's new tool that allows clinicians to ask complex clinical questions using Wolters Kluwer’s UpToDate Expert AI API solution directly within the Suki for Clinicians app.
The tool—dubbed Ask—integrates evidence-based clinical reasoning directly into workflows and can provide answers grounded in UpToDate’s proprietary content. It’s the first product integration of the UpToDate Expert AI API, the companies said.